by intramolecular annulation of dibenzazonine10 and (7) an
assortment of miscellaneous methods.11 Despite the avail-
ability of many synthetic methods for the Erythrina alkaloids,
there still exists a need to develop procedures more efficient
than those currently in existence. In earlier studies, our group
had reported on the use of a tandem Diels-Alder/N-
acyliminium ion cyclization cascade as well as a thionium-
promoted Mannich strategy13 for assemblage of the eryth-
rinan skeleton. In this paper, we describe an alternative
approach to construct the tetracyclic core of the Erythrina
family which makes use of an NBS-induced cyclization of
a hexahydroindolinone derivative.
Scheme 1
12
On the basis of our earlier work with the Erythrina
skeleton, we reasoned that a suitably substituted hexa-
hydroindolinone N-acyliminium ion precursor might allow
for a facile entry to the tetracyclic core of erysotramidine
1
4
(
2) (vide infra). This approach which, in the event, proved
successful was initially tried using several model compounds.
Our synthesis of the starting bicyclic lactam substrates
followed a methodology similar to that previously described
15
in the literature. Condensation of the appropriate amine with
a (1-substituted 2-oxocyclohexyl)acetic acid derivative (i.e.,
reported syntheses of the nonaromatic erythroidine alkaloids
have employed this strategy of assemblage. To demonstrate
17
4
or 5) under Dean-Stark conditions in xylene at 160 °C
that this methodology could also be used for â-phenethyl-
for 1 h afforded the desired bicyclic lactams in high yield.
The resulting aryl lactam precursors (i.e., 6 and 7) were
smoothly converted to the desired tetracyclic products in
essentially quantitative yield when treated with either tri-
fluoroacetic acid (9) or trifluoromethanesulfonic acid (10).
The formation of a single lactam diastereomer is the result
of the stereoelectronic preference for axial attack by the
aromatic ring of the N-acyliminium ion (8) from the least
hindered side (Scheme 1).16
18
amine pharmacophores possessing the homoerythrina skel-
eton, the homologous furan 12 (n ) 2) was subjected to the
acid-catalyzed cyclization conditions (Scheme 2). Interest-
Scheme 2
We were pleased to find that the analogous furanyl-
substituted hexahydroindolinone system 11 also underwent
a related acid-induced cyclization to give the tetracyclic
substituted lactam 14 in 78% yield. This cyclization is
especially noteworthy considering that none of the previously
(8) (a) Sano, T.; Toda, J.; Kashiwaba, N.; Ohshima, T.; Tsuda, Y. Chem.
Pharm. Bull. 1987, 35, 479. (b) Tsuda, Y.; Hosoi, S.; Katagiri, N.; Kaneko,
C.; Sano, T. Heterocycles 1992, 33, 497.
(
9) (a) Danishefsky, S. J.; Panek, J. S. J. Am. Chem.. Soc. 1987, 109,
17. (b) Ahmed-Schofield, R.; Mariano, P. S. J. Org. Chem. 1987, 52, 1478.
c) Irie, H.; Shibata, K.; Matsuno, K.; Zhang, Y. Heterocycles 1989, 29,
033. (d) Kawasaki, T.; Onoda, N.; Watanabe, H.; Kitahara, T. Tetrahedron
Lett. 2001, 42, 8003.
10) (a) Gervay, J. E.; McCapra, F.; Money, T.; Sharma, G. M. J. Chem.
9
(
1
(
Soc., Chem. Commun. 1966, 142. (b) Tanaka, H.; Shibata, M.; Ito, K. Chem.
Pharm. Bull. 1984, 32, 1578. (c) Chou, C. T.; Swenton, J. S. J. Am. Chem.
Soc. 1987, 109, 6898.
(11) (a) Mondon, A.; Ehrhardt, M. Tetrahedron Lett. 1966, 2557. (b)
Haruna, M.; Ito, K. J. Chem. Soc., Chem. Commun. 1976, 345. (c) Ishibashi,
H.; Sato, K.; Ikeda, M.; Maeda, H.; Akai, S.; Tamura, Y. J. Chem. Soc.,
Perkin Trans. 1 1985, 605. (d) Westling, M.; Smith, R.; Livinghouse, T. J.
Org. Chem. 1986, 51, 1159. (e) Chikaoka, S.; Toyao, A.; Ogasawara, M.;
Tamura, O.; Ishibashi, H. J. Org. Chem. 2003, 68, 312.
ingly, the only product isolated in 54% yield corresponded
to the novel dimeric furanyl bis-lactam 15 which is derived
by bimolecular trapping of the N-acyliminium ion at the more
(
12) (a) Padwa, A.; Kappe, C. O.; Reger, T. S. J. Org. Chem. 1996, 61,
4
1
888. (b) Padwa, A.; Hennig, R.; Kappe, C. O.; Reger, T. S. J. Org. Chem.
998, 63, 1144.
(16) (a) Wilkens, H. J.; Traxler, F. HelV. Chim. Acta 1975, 58, 1512.
(b) Mondon, A.; Hansen, K. F.; Boehme, K.; Faro, H. P.; Nestler, H. J.;
Vilhuber, H. G.; B o¨ ttcher, K. Chem. Ber. 1970, 103, 615. (c) Mondon, A.;
Nestler, H. J. Chem. Ber. 1979, 112, 1329. (d) Dean, R. T.; Rapoport, H.
A. J. Org. Chem. 1978, 43, 4183.
(
13) Padwa, A.; Waterson, A. G. J. Org. Chem. 2000, 65, 235.
(14) (a) Ito, K.; Suzuki, F.; Haruna, M. J. Chem. Soc., Chem. Commun.
1
978, 733. (b) Tsuda, Y.; Hosoi, S.; Katagiri, N.; Kaneko, C.; Sano, T.
Chem. Pharm. Bull. 1993, 41, 2087. (c) Hosoi, S.; Nagao, M.; Tsuda, Y.;
Isobe, K.; Sano, T.; Ohta, T. J. Chem. Soc., Perkin Trans. 1 2000, 1505.
(17) The â-erythroidine skeleton has been prepared by an oxidative
degradation of the aromatic ring (ring A) in erythrinans as the key step;
see: Isobe, K.; Mohri, K.; Itoh, Y.; Toyokawa, Y.; Takeda, N.; Taga, J.;
Hosoi, S.; Tsuda, Y. Chem. Pharm. Bull. 1992, 40, 2632.
(15) (a) Ragan, J. A.; Claffey, M. C. Heterocycles 1995, 41, 57. (b) Ennis,
M. D.; Hoffman, R. L.; Ghazal, N. B.; Old, D. W.; Mooney, P. A. J. Org.
Chem. 1996, 61, 5813.
(18) Bentley, K. W. Nat. Prod. Rep. 2001, 18, 148.
5068
Org. Lett., Vol. 5, No. 26, 2003